NDS

Nelnet Announces Reduction of Staff Due to Contract Changes Impacting Student Loan Servicing

Retrieved on: 
Thursday, March 23, 2023

On March 22, 2023, Nelnet received a contract modification from the Department of Education (Department) for the company's current loan servicing contracts with the Department.

Key Points: 
  • On March 22, 2023, Nelnet received a contract modification from the Department of Education (Department) for the company's current loan servicing contracts with the Department.
  • Additionally, last month, the Department notified Nelnet of its intent to transfer 1 million borrowers from Nelnet Loan Servicing to another federal servicer.
  • Nelnet will also look for redundancies and efficiencies throughout the year related to the conclusion of projects centered on the consolidation of select loan servicing platforms.
  • Regarding its loan servicing systems, Nelnet continues to develop modern, innovative technology platforms to support federal and consumer loan servicing, respectively.

Intellias Expands in the Americas with New Offices in Bogotá, Colombia

Retrieved on: 
Tuesday, March 21, 2023

CHICAGO , March 21, 2023 /PRNewswire/ -- Intellias, a major provider of consulting and software engineering services to the auto industry, is expanding in the Americas with a new development center in Bogotá, Colombia. 

Key Points: 
  • CHICAGO , March 21, 2023 /PRNewswire/ -- Intellias, a major provider of consulting and software engineering services to the auto industry, is expanding in the Americas with a new development center in Bogotá, Colombia.
  • Intellias currently has offices in Chicago and in Boca Raton, Florida.
  • Intellias opened new offices in Croatia, Bulgaria, Poland, Portugal and Spain and acquired Digitally Inspired, a fast-growing UK-based development company focused on retail and e-commerce business sectors.
  • For the Automotive Portable Kit, Intellias used SoC functionality for in-vehicle infotainment systems and an integrated digital cockpit.

Bright Data CEO Advises UK Politicians on Need for Industry-Led Public Web Data Regulation

Retrieved on: 
Tuesday, March 14, 2023

Or Lenchner, CEO of the industry-leading public web data platform Bright Data, last month joined members of the UK Parliament at a roundtable discussion looking at issues around ethics and regulation in data and alternative intelligence (AI).

Key Points: 
  • Or Lenchner, CEO of the industry-leading public web data platform Bright Data, last month joined members of the UK Parliament at a roundtable discussion looking at issues around ethics and regulation in data and alternative intelligence (AI).
  • He outlined how, as a responsible leader in the web data domain, Bright Data is taking steps to self-regulate and, hopefully, set ethical standards that point the way to effective regulation.
  • As one of the world’s biggest public web data platforms, Bright Data feels a sense of responsibility to help ensure that data is collected and used in the most ethical ways.
  • Participation in the Inquiry is a continuation of Bright Data’s support for the UK Government in implementing the National Data Strategy (NDS).

Nelnet Announces Changes to Staffing Capacity in Student Loan Servicing Division

Retrieved on: 
Wednesday, January 18, 2023

LINCOLN, Neb., Jan. 18, 2023 /PRNewswire/ -- Nelnet (NYSE: NNI) today announced changes to manage excess staff capacity due to delays in the government's student debt relief and return to repayment programs.

Key Points: 
  • LINCOLN, Neb., Jan. 18, 2023 /PRNewswire/ -- Nelnet (NYSE: NNI) today announced changes to manage excess staff capacity due to delays in the government's student debt relief and return to repayment programs.
  • Nelnet has a long history of providing high-quality, customer-focused student loan services—and having highly trained, qualified associates is a key component of that success.
  • Because of Nelnet's commitment to customers, its loan servicing centers have remained open and fully staffed throughout the pandemic and to date.
  • Nelnet remains committed to supporting the millions of federal student loan borrowers who will be entering repayment when the temporary pause ends later in the year.

REDUVO™ Marketing Approval on the Right Path

Retrieved on: 
Thursday, December 22, 2022

The Company will be submitting the response to Health Canada within the allowed timeframe.

Key Points: 
  • The Company will be submitting the response to Health Canada within the allowed timeframe.
  • Questions/feedback from Health Canada are received as the review of the dossier progresses through different review streams.
  • It is also used to treat weight loss and severe nausea in people living with HIV infection.
  • The active pharmaceutical ingredient in REDUVO™ is dronabinol, also known as THC, a synthetic form of the active natural substance in cannabis.

NorthStar Digital Solutions Named 2022 Top Tech Startup by Food Logistics, Supply & Demand Chain Executive

Retrieved on: 
Wednesday, December 14, 2022

MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Food Logistics, the only publication exclusively covering the movement of product through the global cold food supply chain and Supply & Demand Chain Executive, the only publication covering the entire global supply chain, have selected NorthStar Digital Solutions (NDS) as a 2022 Top Tech Startup, which spotlights top software and technology startups in the supply chain and logistics space.

Key Points: 
  • MISSISSAUGA, Ontario, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Food Logistics, the only publication exclusively covering the movement of product through the global cold food supply chain and Supply & Demand Chain Executive, the only publication covering the entire global supply chain, have selected NorthStar Digital Solutions (NDS) as a 2022 Top Tech Startup, which spotlights top software and technology startups in the supply chain and logistics space.
  • "From seed funding rounds to launching new solutions, many of today's tech startups are poised to disrupt the supply chain space.
  • They're introducing new innovations, improving user experiences and striving for that safer, smarter, more efficient supply chain," comments Marina Mayer, Editor-in-Chief of Food Logistics and Supply & Demand Chain Executive.
  • Supply & Demand Chain Executive is the only supply chain publication covering the entire global supply chain, focusing on trucking, warehousing, packaging, procurement, risk management, professional development and more.

VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults

Retrieved on: 
Thursday, December 8, 2022

It can be expected that hepatitis D will also be prevented by immunization with PreHevbrio as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection.

Key Points: 
  • It can be expected that hepatitis D will also be prevented by immunization with PreHevbrio as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection.
  • VBIs hepatitis B vaccine is the only 3-antigen hepatitis B vaccine, comprised of the three hepatitis B surface antigens of the hepatitis B virus S, pre-S1, and pre-S2.
  • VBI Vaccines Inc. (VBI) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease.
  • VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel.

Interactive Display Market Size to Reach USD 18.81 Billion in 2030| Emergen Research

Retrieved on: 
Thursday, December 15, 2022

VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ -- The interactive display market size reached USD 9.46 Billion in 2021 and is expected to register a CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ -- The interactive display market size reached USD 9.46 Billion in 2021 and is expected to register a CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research .
  • Increasing demand for interactive whiteboard for educational applications is a key factor driving interactive display market revenue growth.
  • A teacher can effortlessly communicate text, screen, video, and audio files with students when using an interactive display.
  • The interactive display market is expected to register a CAGR of 8.1% over the forecast period and revenue is projected to increase from USD 9.46 Billion in 2021 to USD 18.81 Billion in 2030.

Interactive Display Market Size to Reach USD 18.81 Billion in 2030 | Emergen Research

Retrieved on: 
Thursday, December 15, 2022

VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ -- The interactive display market size reached USD 9.46 Billion in 2021 and is expected to register a CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research .

Key Points: 
  • VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ -- The interactive display market size reached USD 9.46 Billion in 2021 and is expected to register a CAGR of 8.1% during the forecast period, according to latest analysis by Emergen Research .
  • Increasing demand for interactive whiteboard for educational applications is a key factor driving interactive display market revenue growth.
  • A teacher can effortlessly communicate text, screen, video, and audio files with students when using an interactive display.
  • The interactive display market is expected to register a CAGR of 8.1% over the forecast period and revenue is projected to increase from USD 9.46 Billion in 2021 to USD 18.81 Billion in 2030.

Tetra Bio-Pharma Provides Update on Its REDUVO™ New Drug Submission

Retrieved on: 
Friday, November 18, 2022

MONTREAL, Nov. 18, 2022 /PRNewswire/ -Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development is providing its shareholders with a regulatory status update on the REDUVO New Drug Submission (NDS).

Key Points: 
  • MONTREAL, Nov. 18, 2022 /PRNewswire/ -Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development is providing its shareholders with a regulatory status update on the REDUVO New Drug Submission (NDS).
  • On December 30, 2020, the Company submitted its first new drug submission ("NDS") for the REDUVO soft gel capsules to Health Canada to obtain approval and a drug identification number ("DIN") for the prescription drug.
  • On November 16, the Company received a Clarification Request (Clarifax) from Health Canada regarding the product labels.
  • The active pharmaceutical ingredient in REDUVO is dronabinol, also known as THC, a synthetic form of the active natural substance in cannabis.